Navigation Links
Novation Announces the Addition of St. Jude Medical to the Cardiac Rhythm Management Products Portfolio

IRVING, Texas, April 8, 2011 /PRNewswire/ -- Novation, the leading health care supply contracting company, announced today the addition of St. Jude Medical (St. Paul, MN) to its portfolio of agreements for Cardiac Rhythm Management products.

St. Jude Medical is a leading provider of medical devices which treat cardiac, neurological and chronic pain patients. The company provides a full portfolio of arrhythmia management products, including pacemakers, implantable cardioverter defibrillators (ICDs) and leads.

Effective April 1, 2011 the agreement features a complete product offering, locally-negotiated pricing and market share growth rebates as well as price protections and transparency offered through GPO contracts. The new 30-month agreement marks the first collaboration between Novation and St. Jude Medical.

"We are pleased to partner with Novation and their member hospitals to provide additional access to St. Jude Medical's life sustaining technologies. The new agreement has the potential to both increase the use of our arrhythmia management therapies and help to create efficiencies in the supply chain," said Mike Rousseau, Group President of St. Jude Medical.

During Novation's due diligence in this product category, the members of VHA Inc., the University HealthSystem Consortium (UHC) and Provista were overwhelmingly supportive of St. Jude Medical and their products. The products were viewed as both innovative and relevant to meeting their needs of providing quality care at an appropriate price.

"We are excited about the new agreement with St. Jude Medical and how it rounds out our already strong portfolio in this space. We view their products as being both innovative and relevant to meeting the needs of our members," said Pete Allen, senior vice president, sourcing operations at Novation. "We are looking forward to St. Jude Medical's pipeline of new technologies, many which we expect to soon be available in the United States, such as ShockGuard for reduction of inappropriate therapies, quadripolar CRT-D systems, and technologies focused on hemodynamic monitoring for heart failure patient management."

The following products will be available to the members of VHA Inc., UHC and Provista:

  • Pacemakers
  • Implantable Cardioverter Defibrillators (ICD)
  • Heart Failure Devices (CRT-D)
  • Leads
  • Patient Home Monitoring Systems
  • Accessories

About Novation

Founded in 1998, Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances, and 5,500 members of Provista, LLC, representing 28,000 sites. Novation provides alliance members contract and price management and spend management services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC and Provista members used Novation contracts to purchase nearly $39 billion in 2010.

SOURCE Novation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Honored for Diagnostic Innovation at 2011 Edison Awards
2. Freedom Innovations Opens New European Headquarters
3. Awarepoint CEO Jay Deady to Serve as Panelist at IBFs Digital Healthcare Innovation Summit
4. Inovio Pharmaceuticals Receives U.S. DOD Small Business Innovation Research Grant for Multi-Vaccine DNA Delivery Device Development
5. Lilly CEO Calls for Biopharmaceutical Industry Changes and Policies That Encourage Medical Innovation
6. Echo Therapeutics Receives Frost & Sullivans 2011 Technology Innovation Award
7. NorTech, Crains Cleveland Business Announce 2011 Innovation Award Winners
8. Medtronic Inc. Cancels Cardiovascular and Orthopedic Contracts With Novation
9. Enox Biopharma, Inc. to Present at IN3 West Investment in Innovation Conference.
10. CVS Caremark Awarded Pharmacy Benefit Management Institute Rx Benefit Innovation Award for Pharmacy Advisor Program
11. Reportlinker Adds Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
Post Your Comments:
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
Breaking Medicine News(10 mins):